NYLIM
BSX icon

New York Life Investment Management’s Boston Scientific BSX Stock Holding History

New York Life Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Buy
220,446
+5,780
+3% +$462K 0.12% 154
2025
Q4 		$20.5M Buy
214,666
+13,458
+7% +$1.32M 0.18% 111
2025
Q3 		$19.6M Sell
201,208
-4,649
-2% -$481K 0.17% 115
2025
Q2 		$22.1M Buy
205,857
+3,790
+2% +$383K 0.21% 94
2025
Q1 		$20.4M Sell
202,067
-1,227
-0.6% -$124K 0.21% 102
2024
Q4 		$18.2M Buy
203,294
+2,488
+1% +$219K 0.18% 108
2024
Q3 		$16.8M Sell
200,806
-6,082
-3% -$479K 0.16% 122
2024
Q2 		$15.9M Buy
206,888
+1,017
+0.5% +$74.4K 0.16% 128
2024
Q1 		$14.1M Sell
205,871
-7,232
-3% -$465K 0.14% 140
2023
Q4 		$12.3M Sell
213,103
-1,207
-0.6% -$64.4K 0.13% 150
2023
Q3 		$11.3M Buy
214,310
+6,039
+3% +$317K 0.12% 151
2023
Q2 		$11.3M Buy
208,271
+2,020
+1% +$106K 0.12% 157
2023
Q1 		$10.3M Buy
206,251
+872
+0.4% +$41.1K 0.11% 179
2022
Q4 		$9.5M Sell
205,379
-527
-0.3% -$22.8K 0.11% 199
2022
Q3 		$7.97M Buy
205,906
+1,414
+0.7% +$56.7K 0.1% 221
2022
Q2 		$7.62M Buy
+204,492
New +$8.32M 0.09% 238

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New York Life Investment Management's BSX Position: Q1 2026 in Review

New York Life Investment Management increased its Boston Scientific (BSX) stake by 2.7% in Q1 2026, buying an estimated $462K and bringing the position to 220,446 shares worth $13.8M. The position accounts for 0.12% of the portfolio, ranked #154.

New York Life Investment Management first reported a position in BSX in Q2 2022 and has held it in 16 quarters since. The position peaked at $22.1M in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • New York Life Investment Management held 220,446 shares of Boston Scientific worth $13.8M as of Q1 2026.
  • New York Life Investment Management bought 5,780 Boston Scientific shares in Q1 2026, an estimated $462K.
  • Boston Scientific made up 0.12% of New York Life Investment Management's portfolio in Q1 2026, its #154 holding.
  • New York Life Investment Management first reported a position in Boston Scientific in Q2 2022 and has held it in 16 quarters since.
  • New York Life Investment Management's Boston Scientific position peaked at $22.1M in Q2 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.